Open Access Open Access  Restricted Access Subscription Access

Exploring the Mechanisms of Action of Anti emetic Drugs

Muralinath E., Pooja Devi, Prasanta Chbukdhara, Sanjib Borah, Kalyan C., Archana Jain, Guruprasad M.

Abstract


Antiemetic drugs play an important role in managing the distressing symptoms.  Serotonin receptor antagonists namely ondonsetron and granisetron and perform the work by stopping  ( 5 HT 3 ) receptors in the GIT and CNS. Dopamine is related to the sensation of nausea. Drugs like metaclopramide and prochlorperazine behave as Dopamine receptor antagonists. NK/ receptor antagonists namely aperpitant and fosaprepitant influence the action of substance P in the brain. Cannabinoids namely drombinol and nabilone act on these receptors and modulate thecrelease of neurotransmitters precipitated in the emetic reflex. Anti histamine ( H 1 histamine receptors) are seen in the vestibular system and the CTZ will play a role regarding development of motion sickness and nausea. Antihistamines namely dimenhydrinate and meclizine and decrease these receptors and provide relief from nausea and vomiting associated with motion sickness and other vestibular disturbances. Benzodiazepines namely lorazepan show their antiemetic effects through CNS depression. A very few anti emetics namely domperidone behave as prokinetic agents. Prokonetic agents increase gastro intestinal motility and decrease gastric stasis and nausea also. Glucocorticoids namely dexamethasone consists of an anti emetic properties especially in the context of chemotherapy _induced nausea and vomiting. Finally it is concluded that anti emetic drugs provide relief to individuals undergoing various medical treatments.


Full Text:

PDF

References


Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, Watcha M, Chung F, Angus S, Apfel CC, Bergese SD, Candiotti KA, Chan MT, Davis PJ, Hooper VD, Lagoo-Deenadayalan S, Myles P, Nezat G, Philip BK, Tramèr MR., Society for Ambulatory Anesthesia. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014 Jan;118(1):85-113. [PubMed]

Abdelsayed GG. Management of radiation-induced nausea and vomiting. Exp Hematol. 2007 Apr;35(4 Suppl 1):34-6. [PubMed]

Flake ZA, Linn BS, Hornecker JR. Practical selection of antiemetics in the ambulatory setting. Am Fam Physician. 2015 Mar 01;91(5):293-6. [PubMed]

Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001 Dec 03;111 Suppl 8A:106S-112S. [PubMed]

.Horn CC, Wallisch WJ, Homanics GE, Williams JP. Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting. Eur J Pharmacol. 2014 Jan 05;722:55-66. [PMC free article] [PubMed]

Jordan K, Schmoll HJ, Aapro MS. Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol. 2007 Feb;61(2):162-75. [PubMed]

Tavorath R, Hesketh PJ. Drug treatment of chemotherapy-induced delayed emesis. Drugs. 1996 Nov;52(5):639-48. [PubMed]

Cite as: Muralinath E., Pooja Devi, Prasanta Chbukdhara, Sanjib Borah, Kalyan C., Archana Jain, & Guruprasad M. (2024). Exploring the Mechanisms of Action of Anti emetic Drugs. Journal of Advancement in Immunology, 1(1), 26–28. https://doi.org/10.5281/zenodo.10837409

Clissold SP, Heel RC. Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985 Mar;29(3):189-207. [PubMed]

dos Santos LV, Souza FH, Brunetto AT, Sasse AD, da Silveira Nogueira Lima JP. Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review. J Natl Cancer Inst. 2012 Sep 05;104(17):1280-92. [PubMed]

Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010 Jan;31(1):11-9. [PubMed]


Refbacks

  • There are currently no refbacks.